An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (Q34206291)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis |
scientific article |
Statements
1 reference
An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis (English)
1 reference
Rebecca A Marsh
1 reference
Mi-Ok Kim
1 reference
Chunyan Liu
1 reference
Denise Bellman
1 reference
Laura Hart
1 reference
Michael Grimley
1 reference
Ashish Kumar
1 reference
Sonata Jodele
1 reference
Kasiani C Myers
1 reference
Sharat Chandra
1 reference
Tom Leemhuis
1 reference
Parinda A Mehta
1 reference
Jack J Bleesing
1 reference
Stella M Davies
1 reference
Michael B Jordan
1 reference
Alexandra H Filipovich
1 reference
10 September 2013
1 reference
1 reference
19
1 reference
11
1 reference
1625-1631
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference